Takayoshi Ohkubo Selected Research

Takayoshi Ohkubo Research Topics

Disease

74	Hypertension (High Blood Pressure) 04/2022 - 03/2002
24	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2003
24	Stroke (Strokes) 01/2021 - 09/2003
16	Essential Hypertension 08/2019 - 02/2002
14	Diabetes Mellitus 01/2020 - 04/2007
11	Obesity 04/2019 - 12/2004
10	Hypercholesterolemia 07/2018 - 12/2004
9	White Coat Hypertension 08/2013 - 07/2005
8	Chronic Renal Insufficiency 01/2021 - 12/2008
8	Masked Hypertension 08/2013 - 08/2005
7	Coronary Disease (Coronary Heart Disease) 01/2021 - 10/2002
6	Atherosclerosis 11/2018 - 09/2014
5	Heart Failure 12/2019 - 05/2008
4	Myocardial Infarction 08/2018 - 10/2002
4	Heart Diseases (Heart Disease) 08/2015 - 09/2006
3	Insulin Resistance 01/2022 - 09/2010
3	Proteinuria 01/2022 - 12/2008
3	Neoplasms (Cancer) 10/2019 - 11/2018
3	Overweight 04/2019 - 11/2015
3	Hyperlipidemias (Hyperlipidemia) 04/2019 - 12/2008
3	Body Weight (Weight, Body) 01/2018 - 10/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2016 - 09/2013
3	Lacunar Stroke 04/2011 - 04/2007
2	Dyslipidemias (Dyslipidemia) 03/2021 - 01/2015
2	Cerebral Hemorrhage 02/2019 - 02/2006
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2004
2	Cognitive Dysfunction 01/2018 - 09/2003
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2017 - 04/2011
2	Hyperaldosteronism (Conn Syndrome) 08/2012 - 03/2011
2	Cerebral Infarction 01/2012 - 02/2006
2	Renal Insufficiency (Renal Failure) 07/2010 - 10/2004
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2008 - 09/2003
2	Vascular Diseases (Vascular Disease) 09/2003 - 12/2002
2	Unstable Angina 12/2002 - 10/2002
1	Periodontitis 06/2022
1	Alveolar Bone Loss 06/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	COVID-19 10/2020
1	Gout 01/2020
1	Birth Weight (Birth Weights) 01/2020
1	Hyperuricemia 01/2020

Drug/Important Bio-Agent (IBA)

57	Antihypertensive Agents (Antihypertensives)IBA 04/2022 - 05/2002
9	HDL CholesterolIBA 01/2018 - 01/2014
8	SaltsIBA 02/2015 - 09/2002
7	CholesterolIBA 01/2021 - 01/2012
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 04/2003
7	LipidsIBA 07/2018 - 09/2013
7	AldosteroneIBA 02/2015 - 03/2011
6	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2003
5	ORALIT (ORS)IBA 06/2022 - 01/2017
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 06/2008
5	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2014
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020 - 03/2002
5	CreatinineIBA 11/2018 - 12/2008
5	PotassiumIBA 01/2018 - 07/2008
5	ReninIBA 02/2015 - 09/2002
5	mahuang-tangIBA 11/2010 - 08/2005
4	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2020 - 08/2015
4	SodiumIBA 01/2018 - 03/2011
4	C-Reactive ProteinIBA 01/2018 - 01/2015
4	Dietary SodiumIBA 01/2017 - 03/2011
4	CalciumIBA 03/2016 - 04/2003
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2010
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2017
3	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2015
3	pro-brain natriuretic peptide (1-76)IBA 12/2019 - 08/2015
3	Angiotensin IIIBA 08/2005 - 03/2002
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2012
2	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2021 - 08/2013
2	Uric Acid (Urate)IBA 01/2021 - 01/2020
2	A-factor (Streptomyces)IBA 01/2021 - 10/2004
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2019 - 01/2014
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2018 - 03/2016
2	HDL LipoproteinsIBA 01/2018 - 04/2015
2	Irbesartan FDA LinkGeneric 10/2017 - 01/2016
2	Amlodipine (Norvasc)FDA LinkGeneric 10/2017 - 06/2008
2	DiureticsIBA 10/2017 - 11/2006
2	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 10/2017 - 04/2007
2	Losartan (Cozaar)FDA LinkGeneric 01/2016 - 08/2005
2	Valsartan (Vals)FDA Link 01/2016 - 08/2005
2	Telmisartan (Micardis)FDA Link 01/2016 - 08/2005
2	candesartanIBA 01/2016 - 08/2005
2	Hemoglobins (Hemoglobin)IBA 01/2015 - 12/2004
2	Fibrinogen (Factor I)FDA Link 01/2015 - 04/2007
2	AlbuminsIBA 11/2012 - 02/2009
2	AngiotensinogenIBA 06/2012 - 07/2002
2	Prorenin ReceptorIBA 04/2011 - 12/2009
2	Peptides (Polypeptides)IBA 07/2010 - 05/2008
2	AdrenomedullinIBA 07/2010 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 02/2009 - 06/2008
2	urotensin IIIBA 05/2008 - 10/2004
1	antiarrhythmic peptide (AAP)IBA 06/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2022

Therapy/Procedure

10	Therapeutics 01/2022 - 04/2003
2	Ambulatory Care (Outpatient Care) 03/2021 - 09/2004
2	Palliative Care (Palliative Therapy) 01/2019 - 11/2018
2	Activities of Daily Living (ADL) 05/2018 - 02/2016
2	Ligation 12/2009 - 05/2008
1	Blood Pressure Monitors 01/2021